Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC4902 Ssm3 Tfa Salt

Potent furin inhibitor, blocking furin-dependent cell surface processing of anthrax protective antigen-83 in vitro.

922732-52-3
DCC4903 SS-nf-atra

Novel chimeric degrader against cellular retinoic acid binding proteins (CRABPs), inducing the AhR-dependent degradation of CRABP-1 and CRABP-2 via the ubiquitin-proteasome pathway

DCC4904 SS-nf-jq1

Novel chimeric degrader against bromodomain-containing (BRD) proteins, inducing the interaction of AhR and BRD proteins and displaying effective anticancer activity that correlated with protein knockdown activity

DCC4905 SS-nicotinamide Adenine Dinucleotide, Reduced Disodium

Cofactor for mitochondrial deacetylase sirtuin-3 enzyme, regulating energy metabolism and immunity and modulating inflammasome assembly

606-68-8
DCC4906 Ssr126768a

Novel Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor

785048-28-4
DCC4907 Ssr180575 Featured

SSR-180,575 is a drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO. It has been shown to have neuroprotective and cardioprotective effects and to stimulate steroidogenesis of pregnenolone in the brain, which may be linked to its neuroprotective action.

220448-02-2
DCC4908 SS-thujaplicinol

Inhibitor of the replication of herpes simplex viruses 1 and 2 (HSV-1 and HSV-2)

4356-35-8
DCC4909 Sstr3-agonist-5c

Novel non-peptidic highly potent somatostatin receptor 3 (SSTR3) agonist

DCC4910 Sstr3-antagonist-3a

Novel potent sstr3 antagonist, showing to reduce glucose excursion in a mouse oGTT assay

DCC4911 Sstr5a

Novel somatostatin receptor subtype 5 antagonist, stimulating glucoseinduced GLP-1 secretion, reducing blood glucose in a gut- and GLP-1R-dependent manner

DCC4912 St026567

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

5067-25-4
DCC4913 St029248

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

96-69-5
DCC4914 St056083

Novel inhibitor of the c-di-AMP synthetase DNA integrity scanning protein (DisA) in vitro

299419-24-2
DCC4915 St101036

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

1018143-39-9
DCC4916 st-1032

Novel histamine H3 receptor ligand

DCC4917 St1237

Potent, direct, non-cytotoxic Arachidonate_5-lipoxygenase>5-lipoxygenase (5-LO) inhibitor

1380593-17-8
DCC4918 St-161

Antiviral agent against LASV and a number of other viruses in the Arenaviridae family

DCC4919 St-1703

Novel histamine H3 receptor ligand

DCC4920 St-1892

Novel highly potent and soluble partial FXR agonist

1409411-32-0
DCC4921 St-198

Seletive dopamine D3 receptors

854924-64-4
DCC4922 St-1992

Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL)

DCC4923 St-2001

Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL)

Page 1445 / Total 1558 FirstPrevNextLastGoto